1. Home
  2. IMRN vs CCTG Comparison

IMRN vs CCTG Comparison

Compare IMRN & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

SELL

Current Price

$0.88

Market Cap

7.7M

Sector

Health Care

ML Signal

SELL

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

SELL

Current Price

$0.31

Market Cap

8.9M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
IMRN
CCTG
Founded
1994
1993
Country
Australia
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.9M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
IMRN
CCTG
Price
$0.88
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4K
★ 376.8K
Earning Date
08-28-2026
12-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$0.08
52 Week High
$1.99
$5.64

Technical Indicators

Market Signals
Indicator
IMRN
CCTG
Relative Strength Index (RSI) 34.56 37.50
Support Level $0.75 $0.17
Resistance Level $0.89 $0.36
Average True Range (ATR) 0.07 0.04
MACD 0.00 0.01
Stochastic Oscillator 22.05 37.28

Price Performance

Historical Comparison
IMRN
CCTG

About IMRN Immuron Limited

Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd, through its direct wholly-owned subsidiaries, is principally engaged in the manufacturing and sale of interconnect products, including connectors, cables and wire harnesses. The company produces both original equipment manufacturer (OEM) and original design manufacturer (ODM) interconnect products for manufacturing companies that produce end products, as well as for electronic manufacturing services (EMS) companies. The majority of the company's revenue is derived from the sale of Cable and wire harnesses, and Connectors. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

Share on Social Networks: